Free Trial

Quince Therapeutics (QNCX) Insider Trading & Ownership

→ “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad)
Free QNCX Stock Alerts
$0.92
+0.01 (+1.10%)
(As of 05/9/2024 ET)
Compare
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Quince Therapeutics (NASDAQ:QNCX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
21.00%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$648,111.20
Number Of
Insiders Selling
(Last 12 Months)
0
Get QNCX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Quince Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

QNCX Insider Buying and Selling by Quarter

Ad Unstoppable Prosperity
Charles Payne Demystifies Options
When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio.
Click here to register for free.

Quince Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/14/2023David LamondDirectorBuy22,627$1.04$23,532.08  
12/12/2023David LamondDirectorBuy22,327$1.02$22,773.54  
12/7/2023David LamondDirectorBuy19,123$1.01$19,314.23  
12/5/2023David LamondDirectorBuy19,123$1.01$19,314.23  
12/1/2023David LamondDirectorBuy14,378$0.94$13,515.32  
11/29/2023David LamondDirectorBuy14,378$0.98$14,090.44  
8/30/2023David LamondDirectorBuy41,026$1.31$53,744.06  
8/17/2023David LamondDirectorBuy24,766$1.29$31,948.14  
8/15/2023David LamondDirectorBuy107,886$1.32$142,409.52  
8/10/2023Dirk ThyeCEOBuy88,000$1.26$110,880.00  
8/8/2023Brendan HannahInsiderBuy71,762$1.22$87,549.64  
8/8/2023Dirk ThyeCEOBuy80,000$1.24$99,200.00  
8/8/2023Margaret McloughlinDirectorBuy8,000$1.23$9,840.00  
(Data available from 1/1/2013 forward)

QNCX Insider Trading Activity - Frequently Asked Questions

Who is on Quince Therapeutics's Insider Roster?

The list of insiders at Quince Therapeutics includes Brendan Hannah, David Lamond, Dirk Thye, Margaret Mcloughlin, and Ted Monohon. Learn more on insiders at QNCX.

What percentage of Quince Therapeutics stock is owned by insiders?

21.00% of Quince Therapeutics stock is owned by insiders. Learn more on QNCX's insider holdings.

Which Quince Therapeutics insiders have been buying company stock?

The following insiders have purchased QNCX shares in the last 24 months: Brendan Hannah ($87,549.64), David Lamond ($340,641.56), Dirk Thye ($210,080.00), and Margaret Mcloughlin ($9,840.00).

How much insider buying is happening at Quince Therapeutics?

Insiders have purchased a total of 533,396 QNCX shares in the last 24 months for a total of $648,111.20 bought.

Which Quince Therapeutics insiders have been selling company stock?

The following insider sold QNCX shares in the last 24 months: Ted Monohon ($1,833.58).

How much insider selling is happening at Quince Therapeutics?

Insiders have sold a total of 1,871 Quince Therapeutics shares in the last 24 months for a total of $1,833.58 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:QNCX) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners
The Crypto 9-5 Escape Plan
Crypto 101 Media
Gold Set to EXPLODE!
Gold Safe Exchange
Charles Payne Demystifies Options
Unstoppable Prosperity
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
Banyan Hill Publishing
He Is Giving Away Bitcoin
Crypto Swap Profits
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
The 2024 Gold Rush: Unleashing Market Potential
Priority Gold
[URGENT] DO NOT Touch These AI Stocks!
Weiss Ratings